SavedAdd your journal

Journals / Turkish Journal of Medical Sciences / 2016 / Cilt: 46 - Sayı: 2

Retinopathy of prematurity: incidence, risk factors, and evaluation of screening criteria

Hamza YAZGAN
Haşim USLU
Bülent GÜRLER
Mehmet DEMİRDÖVEN
Alparslan TONBUL
Esengül KELEŞ
Bülent BAŞTÜRK
Aydın YILDIRIM
* Arzu GEBEŞÇE1
Pages
315–320
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this study, birth weight, ventilation treatment, bronchopulmonary dysplasia, and maternal preeclampsia were the most important risk factors for the development of ROP.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: The goal of this study was to investigate the incidence of retinopathy of prematurity (ROP) and the relationship between risk factors and disease in premature newborns in our neonatal intensive care unit.
📊
Key Findings & Data:Materials and methods: A total of 219 premature subjects were retrospectively evaluated for retinopathy.
💡
Conclusion & Impact:Conclusion: In this study, birth weight, ventilation treatment, bronchopulmonary dysplasia, and maternal preeclampsia were the most important risk factors for the development of ROP.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: The goal of this study was to investigate the incidence of retinopathy of prematurity (ROP) and the relationship between risk factors and disease in premature newborns in our neonatal intensive care unit. Materials and methods: A total of 219 premature subjects were retrospectively evaluated for retinopathy. Demographic information, clinical data, and risk factors were reviewed. Results: The gestational ages of the infants included in the study ranged between 25 and 36 weeks, and the birth weights ranged between 670 and 4460 g. In this study, the incidence of ROP was 20.1% (44) in preterm infants: 16 had stage 1 (36.4%), 15 had stage 2 (34.1%), 11 had stage 3 (25%), 1 had stage 4 (2.3%), 1 had stage 5 (2.3%), and 6 had plus (+) disease (7.2%). The risk factors associated with the development of ROP included low birth weight, ventilation treatment, bronchopulmonary dysplasia, and maternal preeclampsia. The risk factors were analyzed with logistic regression analysis. The odds ratios were 5.952 (95% confidence interval [CI]: 2.030 17.447), 20.070 (95% CI: 4.213 95.600), 5.879 (1.916 18.037), and 3.200 (95% CI: 1.002 11.535), respectively. Conclusion: In this study, birth weight, ventilation treatment, bronchopulmonary dysplasia, and maternal preeclampsia were the most important risk factors for the development of ROP.

🔖

Cite This Article

YAZGAN, H., USLU, H., GÜRLER, B., DEMİRDÖVEN, M., TONBUL, A., KELEŞ, E., BAŞTÜRK, B., YILDIRIM, A., GEBEŞÇE1, *. A. (2022). Retinopathy of prematurity: incidence, risk factors, and evaluation of screening criteria. Turkish Journal of Medical Sciences, Cilt: 46 - Sayı: 2, 315–320. https://ajindex.com/articles/610745

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol 1942; 25: 203–204
  2. Hesse L, Eberl W, Schlaud M. Poets CF. Blood transfusion iron load and retinopathy of prematurity. Eur J Pediatr 1997; 156: 465–470
  3. Smolkin T, Steinberg M, Sujov P, Mezer E, Tamir A, Makhoul IR. Late postnatal systemic steroids predispose to retinopathy of prematurity in very low birth weight infants: a comparative study. Acta Paediatr 2008; 97: 322–326
  4. Hellstrom A, Peruzzi C, Ju M, Engtröm E, Hard A, Liu J, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjödell L et al. Low IGF-1 supresses endothelial cells: direct correlation with clinical retinopathy of prematurity. P Natl Acad Sci USA 2001; 98: 5804–5808
  5. Smith LE. Pathogenesis of retinopathy of prematurity. Gowth Horm IGF Res 2004; 14: 140–144
  6. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007; 10: 133–140
  7. Basmak H, Shin A, Erol N, Gursoy HH. Retinopathy of prematurity: screening guidelines need to be reevaluated for developing countries. Eur J Ophthalmol 2010; 20: 752–755
  8. Sarikabadayi YU, Aydemir O, Ozen ZT, Aydemir C, Tok L, Oguz SS, Erdeve O, Uras N, Dilmen U. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: frequency and risk factors. Ophthal Epidemiol 2011; 18: 269–274
  9. Ugurbas SC, Gulcan H, Canan H, Ankarali H, Torer B, Akova YA. Comparison of UK and US screening criteria for detection of retinopathy of prematurity in a developing nation. J AAPOS 2010; 14: 506–510
  10. Akman I, Dmirel U, Yenice O, Ilerisoy H, Kozakoglu H, Ozek E. Screening criteria for retinopathy of prematurity in developing countries. Eur J Ophthalmol 2010; 14: 506–511
  11. Binkhathlan AA, Almahmoud LA, Saleh MJ, Srungeri S. Retinopathy of prematurity in Saudi Arabia: incidence risk factors and the applicability of current screening criteria. Br J Ophthalmol 2008; 92: 167–169
  12. Chen Y, Li X. Characteristics of severe retinopathy of prematurity patients in China: repeat of the first epidemic? Br J Ophthalmol 2006; 90: 268–271
  13. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low weight infants in Singapore. Ann Acad Med Singapore 2005; 34: 169–178
  14. Giannantonio C, Papacci P, Cota F, Vento G, Tesfagabir MG, Purcaro V, Lepore D, Molle F, Baldascino A, Romagnoli C. Analysis of risk factors for progression to treatment –requiri